SPC MW – A New Privilege For Generics Producers?

29 March 2019
Share:
The pharmaceutical industry is divided into two categories of manufacturers: original drug companies and generics companies. Original drug manufacturers are usually those who first look for new molecular targets that could be the target for completely new drugs and then, over the course of laborious and expensive research and development, create new preparations and formulations in order to verify the efficacy of the product in clinical trials, and finally register the new drug.

Full text of article is avalaible in our blog “All rights reserved”.

Warszawa

JWP Patent & Trademark Attorneys
ul. Mińska 75
03-828 Warsaw
Poland
P: 22 436 05 07
E: info@jwp.pl

VAT: PL5260111868
Court Register No: 0000717985

Gdańsk

JWP Patent & Trademark Attorneys
HAXO Building
ul. Strzelecka 7B
80-803 Gdańsk
Poland
P: +48 58 511 05 00
E: gdansk@jwp.pl

Kraków

JWP Patent & Trademark Attorneys
ul. Kamieńskiego 47
30-644 Kraków
Poland
P: +48 12 655 55 59
E: krakow@jwp.pl

Wrocław

JWP Patent & Trademark Attorneys
WPT Bud. Alfa
ul. Klecińska 123
54-413 Wrocław
Poland
T: +4871 342 50 53
E: wroclaw@jwp.pl